What is KYTX's dilution risk score?

KYTX has a latest available DilutionScore record of 52/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for KYTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for KYTX?

DilutionWatch tracks 25 SEC filing types for KYTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect KYTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For KYTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for KYTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for KYTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

KYTX Dilution Risk Score: 52/100 (HIGH)

Score Breakdown

📋 Offering Ability

87

💰 Cash Runway

25

📊 Float Risk

50

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 19%

💰 Capital Raise model 38%

• Active shelf registration ($300M, 58% of market cap)

• Active ATM program with $100M remaining capacity

🔔 Track KYTX — Get forecast alerts →

Market Data

Market Cap$517.98M

Shares Outstanding61.84M

Float35.50M

Cash$199.43M

Debt$24.88M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.3% shares (2026Q1 vs prior)

113 institutional holders · 39.45M shares

#1 GordonMD Global Investments LP 4.24M shares

#2 GILEAD SCIENCES, INC. 4.13M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 3.57M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.18M

Days to Cover8.7

% of Float23.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31

EFFECT EFFECT 2026-04-02

424B5 ATM 2026-04-02

S-3 SHELF 2026-03-26

4 INSIDER TRANSACTION 2026-03-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual KYTX Dilution Snapshot

Kyverna Therapeutics, Inc. (KYTX) has a DilutionScore of 52/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $300.0M.
Stored ATM program remaining capacity: $100.0M.
Recent SEC activity tracked for KYTX: EFFECT on 2026-04-02; 424B5 on 2026-04-02; S-3 on 2026-03-26.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.